← Open Payments lookup

JAMES CREEK: Open Payments

NPI 1619091998 · CALEXICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$413 in 19 payments from 9 companies in 2025. Trend: 2023 $464 · 2024 $401 · 2025 $413

Food & beverage: $413
CompanyPaymentsAmount
Novo Nordisk Inc4$173
Corcept Therapeutics5$79
Xeris Pharmaceuticals, Inc.2$38
Sumitomo Pharma America, Inc.2$36
ABBVIE INC.2$28
Ascensia Diabetes Care Us Inc.1$17
GlaxoSmithKline, LLC.1$15
AstraZeneca Pharmaceuticals LP1$15
Bayer Healthcare Pharmaceuticals Inc.1$14

Products named: Ozempic, Korlym, RECORLEV, GEMTESA, TRELEGY ELLIPTA, FARXIGA, VRAYLAR, CREON.

Industry payments across CA — which companies pay providers there.